← All stocks

Aquestive Therapeutics, Inc.

AQST Scheduled selling only

CIK 0001398733 #3023 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$273.33K

$227.66K on a plan · $45.68K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$273.33K

$0.00 against sales at will

By person

14 insiders · 6 transactions

4.7×

Daniel Barber holds only 4.7 times base salary in stock. $3.14M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.82, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Barber Daniel

President and CEO

—

$227.66K (2) scheduled

−$227.66K

652,317

0.5197%

$3.14M

−21.1%

Korczynski Sherry

Chief Commercial Officer

—

$45.68K (1) scheduled

−$45.68K

235,689

0.1878%

$1.14M

+214.3%

Wargacki Stephen

Chief Science Officer

—

343,552

0.2737%

$1.66M

+31.4%

Boyd Peter E.

Chief People Officer

—

284,024

0.2263%

$1.37M

+19.5%

TOTH A ERNEST JR

Chief Financial Officer

—

283,460

0.2258%

$1.37M

+14.2%

Kraus Carl N

Chief Medical Officer

—

282,475

0.2251%

$1.36M

+12.2%

Cioffi Melina

SVP, Regulatory Affairs

—

273,200

0.2177%

$1.32M

+49.9%

BRAENDER LORI J

Corporate Secretary

—

231,042

0.1841%

$1.11M

−26.2%

Jung Cassie

Chief Operating Officer

—

208,833

0.1664%

$1.01M

−11.2%

BRATTON DOUGLAS K

10% owner

—

199,841

0.1592%

$963.13K

−16.7%

Zalewski Thomas A.

Chief Legal Officer

—

100,000

0.0797%

$481.95K

—

Davis Matthew W.

Chief Development Officer

—

100,000

0.0797%

$481.95K

—

Greenhawt Matthew J.

Chief Medical Officer

—

75,000

0.0598%

$361.46K

—

Krop Julie

Director

—

0.0000%

$0.00

—

Aquestive Therapeutics, Inc.

By person

Individual transactions

What was left out